235-19441-82996
2 vaccinations
8 coded responses
19 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 761 / TX
- Registered
- 2021-02-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-09
Registered in v-safe
-
2021-02-09
Dose 1 — Moderna
-
2021-02-09
Survey response — day 0, dose 1MedDRA: Paranasal sinus discomfort, Upper-airway cough syndrome — Feeling: Fair · Site: Pain · Chills, HeadacheFree text: Sinus pressure and post nasal dripMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Survey response — days 1–6 daily, dose 1MedDRA: Upper-airway cough syndrome — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Post nasal dripMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion — Feeling: Good · Site: Pain · HeadacheFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
-
2021-02-13
Survey response — days 1–6 daily, dose 1MedDRA: Herpes simplex — Feeling: Good · HeadacheFree text: HSVMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-15
- 2021-02-16
-
2021-02-23
Survey response — day 14, dose 1MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: 2 more instances of migraine this week - unusually high frequency of them since vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Survey response — day 21, dose 1MedDRA: Migraine — Feeling: Fair · Be unable to workFree text: Noticed a pattern of 2 migraines per week since first vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Dose 2 — Moderna
-
2021-03-16
Survey response — day 7, dose 2MedDRA: Arthralgia, Chills, Fatigue, Migraine, Myalgia, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: There was no health check on the day following my second vaccination. I experienced fever, chills, fatigue, muscle and joint aches and a migraine in the first 36 hours following second doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-03-31
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-06-08
-
2021-09-09
Survey response — 6 months, dose 2MedDRA: Sinusitis, Viral upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Sinus infection and other viral upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2021-09-09
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-11
Call successfulDoes not wish to fill out VAERS report
- 2022-03-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-09 | Moderna | |
| 2 | 2021-03-09 | Moderna |
Call center
1 call center case
1 successful
Free text
Release 3 — day 0, dose 1
Systemic reaction (other): Sinus pressure and post nasal drip
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Post nasal drip
Systemic reaction (other): Nasal congestion
Systemic reaction (other): HSV
Release 4 — day 14, dose 1
Symptoms: 2 more instances of migraine this week - unusually high frequency of them since vaccination
Release 4 — day 21, dose 1
Symptoms: Noticed a pattern of 2 migraines per week since first vaccination
Release 5 — day 7, dose 2
Systemic reaction (other): There was no health check on the day following my second vaccination. I experienced fever, chills, fatigue, muscle and joint aches and a migraine in the first 36 hours following second dose
Release 9 — 6 months, dose 2
Symptoms: Sinus infection and other viral upper respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Herpes simplex | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release